| Literature DB >> 32728837 |
Juliette Caroline Sorel1,2,3, Geke Marianne Overvliet4, Maaike Gerarda Johanna Gademan5,6, Chantal den Haan7, Adriaan Honig4, Rudolf Wilhelm Poolman5,8,9.
Abstract
Our aim was to assess the effect of perioperative interventions targeting psychological distress on clinical outcome after total knee arthroplasty (TKA). We searched studies on the effect of perioperative interventions focused on psychological distress used in conjunction with TKA on pain, function, and quality of life (QoL) on PubMed, Embase.com, PsycINFO/OVID, CENTRAL, the Cochrane Database of Systematic Reviews, Scopus, and Web of Science. We included 40 studies (22 RCTs, ten cohort studies, and eight quasi-experimental studies) with a total of 3846 patients. We graded the quality of evidence as low for pain and function and as moderate for QoL. Patients receiving music, education, cognitive behavioural therapy, guided imagery, pain coping skills training, Reiki, occupational therapy with self-monitoring, and biofeedback-assisted progressive muscles relaxing training had lower pain scores or declined opioid prescriptions after TKA. Pain coping skills training, audio recording-guided imagery scripts, video promoting self-confidence, psychological therapies by video, Reiki, music, occupational therapy with self-monitoring, education, and psychotherapy improved postoperative functional outcome. Education through an app improved QoL after TKA. The studies in our systematic review show that perioperative interventions targeting psychological distress for patients receiving TKA seem to have a positive effect on postoperative pain, function, and QoL. RCTs with strict methodological safeguards are still needed to determine if perioperative interventions focused on psychological distress should be used in conjunction with TKA. These studies should also assess which type of intervention will be most effective in improving patient-reported outcome measures and declining opioid prescriptions.Entities:
Keywords: Function; Pain; Psychological distress; Quality of life; Total knee arthroplasty
Year: 2020 PMID: 32728837 PMCID: PMC7591436 DOI: 10.1007/s00296-020-04644-y
Source DB: PubMed Journal: Rheumatol Int ISSN: 0172-8172 Impact factor: 2.631
Fig. 1Search strategy and article selection
Overview of included studies
| Type of intervention | Study | Description of intervention | When was the intervention applied? |
|---|---|---|---|
| Music | Allred [ Prospective cohort | I: Easy-listening music with headphones for 20 min | Before and after their first ambulation at the first postoperative day |
| C: 20-min quiet rest period | |||
| Aris [ | I: Additional relaxing music therapy during recovery (< 60 beats per minute) | During recovery | |
| C: Usual care | |||
| Chen [ | I: Five compositions of 30 min soothing piano and Chinese violin music (60–80 beats per minute) | Ward before surgery, in the waiting area of the surgical room and twice during postoperative recovery | |
| C: No music | |||
| Hsu [ | I: Slow relaxing music with slow tempo, low tone and soft melody | Once a day at the 10 a.m. continuous passive motion (CPM) session on the first and second postoperative day | |
| C: No music, required to rest in bed | |||
| Hsu [ | I: Music for 10 min before receiving CPM until the end of the CPM session | During CMP the first and second days after surgery | |
| C: Rest in bed for 10 min before CPM began | |||
| Keshmiri [ | I1: Isolation of noice by soundproof headphones in conjunction to disposable earplugs | During surgery, after the effect of sedative (Propofol) was applied | |
| I2: Music of patients' choice with headphones | |||
| C: No isolation of noise or music | |||
| Leonard [ | I: Co-treatment session that used live music to support exercise | Postsurgery, after admission to the inpatient rehabilitation unit | |
| C: Physiotherapy without music | |||
Santhna [ QES | I: Music for five days post-operatively and analgesics | 5 days postoperatively | |
| C: No music, only pharmacological intervention | |||
| Simcock [ | I: Music of patients' choice with headphones | During surgery, after a spinal-epidural anaesthesia and sedation with propofol | |
| C: White noise emanating from the headphones | |||
| Education | Atabaki [ | I: Educational intervention presented as a combination of lecture, group discussion, individual education, questions and answers | Four perioperative stages (one day before surgery, 24 h and 48 h later, upon discharge from the hospital) |
| C: Usual care | |||
| Aytekin [ | I: Education (about OA, joint protection, home safety, and TKA) and home-based exercise | During 12 weeks before the operation | |
| C: No additional training program, usual care | |||
| Chen [ | I: Cognitive-behavioural educational intervention (pamphlet, CD and oral instructions) | Before surgery after hospitalisation and 1 days postsurgery | |
| C Routine care and usual instructions delivered orally | |||
| Huang [ | I: 40-min preoperative home rehabilitation education program by a physiotherapist | 2–4 weeks prior to admission | |
| C: No education program | |||
| Huang [ | I: Traditional education, telephone education and mobile education | Following surgery | |
| C: Traditional face-to-face and telephone education | |||
| Lee [ | I1: Psychoeducation on CPSP and prerecorded hypnotic intervention using audiotapes | One delivered before and another delivered at least 24 h after surgery | |
| I2: Psychoeducation on CPSP and diaphragmatic breathing relaxation exercise | |||
| C: Usual care | |||
| Lin [ | I: One-to-one less than 30 min preadmission preoperative teaching* | Preadmission preoperative | |
| C: Postadmission preoperative teaching and no video | |||
| Louw [ | I: Education program and an additional 30-min group pain neuroscience education session | Before surgery | |
| C: Only education program | |||
| Malletschek [ | I: Additional pain psychoeducation over at least 45 min | 3–6 days after TKA | |
| C: Usual care | |||
| Moulton [ | I: Joint school by members of a multidisciplinary group explaining the process of the surgery | Preoperative for 2 h | |
| C: No joint school | |||
| Piva [ | I: Interactive education to promote physical activity and healthy eating | During 3 months postoperative: 2 lectures during the first postoperative week and mini-sessions of physical activity promotion in the subsequent weeks | |
| C: No education | |||
| Reslan [ | I: One to one intervention (30–40 min) including education and exercise training by a nurse | Prior to surgery | |
| C: Standard hospital care | |||
| Timmers [ | I: Day-to-day postoperative care information related to topics such as pain, physiotherapy exercises, wound care, and daily self-care activities through an application | During the 28-day period after discharge | |
| C: Only weekly, basic information | |||
| Wilson [ | I: Usual teaching and preoperative educational intervention** | Teaching session and booklet within 4 weeks prior to surgery Phone call during a week before surgery | |
| C: Usual teaching | |||
| Yajnik [ | I: Pain management educational card*** | Prior to peripheral nerve block placement on the day of surgery, at the time of ward admission by the bedside nurse and once daily during rounds | |
| C: Before implementation of pain management educational card | |||
| Psychotherapy | Birch [ | I: CBT based pain education of approximately 45 min delivered by 2 physiotherapists | 3 sessions preoperatively and 4 sessions postoperatively (2 weeks before surgery until 3 months after surgery) |
| C: Usual care | |||
| Cai [ | I: CBT | After TKA | |
| C: No CBT | |||
| Cai [ | I: Individually tailored CBT by a physiotherapist and a psychologist | During 4 weeks after surgery | |
| C: No CBT | |||
| Das Nair [ | I: 10 sessions of CBT during hour-long sessions by one or two psychologists | During waiting time for surgery | |
| C: No CBT | |||
| Harnirattisai [ | I: 25-min sessions of nurse-patient interaction and discussion**** | At the fourth postoperative day and two weeks after surgery | |
| C: No behavioural change intervention | |||
| Jacobson [ | I: 19- to 21- minute audio recordings of guided imagery$ scripts designed for TKA patients | Every day for two weeks before surgery and three weeks after surgery | |
| C: Commercially available 17- to 21-min audio recordings | |||
| Riddle [ | I: Intervention delivered by trained psychologists# | During 8 weekly sessions from approximately one month prior to surgery to one month after surgery | |
| C: No intervention | |||
| Riddle [ | I1: Eight 50-min sessions of 1-on-1 pain coping skills training | Approximately 2 weeks preoperatively to approximately 6 weeks postoperatively | |
| I2: Eight 50-min sessions of 1-on-1 arthritis education by registered nurses | |||
| C: Usual care | |||
| Russo [ | I: Video according to the Videoinsight Methods^ principles | Three times a week during the first 3 months after surgery | |
| C: No video | |||
| Tristaino [ | I: Four psychologist-patient sessions of 30 min focusing on defining the psychological themes and concepts on which to focus the activity | One before surgery, two during postoperative hospital stay and one during rehabilitation | |
| C: Standard of care | |||
| Remaining | Baldwin [ | I1: Three or four 30-min Reiki treatments provided by three expert Reiki professionals | During the hospital stay |
| I2: Standard of care and three or four sham Reiki session delivered by non-trained people | |||
| C: Standard of care and sessions of “quiet time” | |||
| Christiansen [ | I: Standard of care rehabilitation plus weight baring biofeedback training | On the morning before surgery (20 min) and after admission to the post anaesthesia care unit (30 min) and 20 min at the first, second and third postoperative day | |
| C:Standard of care rehabilitation alone | |||
| Hiraga [ | I: Occupational therapy & self-monitoring using a diary | From 1 to 2 weeks postoperatively | |
| C: Occupational therapy only | |||
| Koo [ | I: Enhanced reality analgesia | Shortly after physiotherapy for 5 times a week, for 2 weeks | |
| C: No enhanced reality analgesia | Shortly after physiotherapy for 5 times a week, for 1 week | ||
| Notte [ | I: Weight bearing (WB) biofeedback-assisted progressive muscle relaxation training sessions using a Nintendo Wii fit Plus game and associated Wii balance board | Twice weekly at home for 6 weeks after surgery | |
| C: Standard of care | |||
| Wang [ | I: CPM therapy and 30-min biofeedback relaxation training | One day before surgery and twice a day on the five first postoperative days, concurrent with CPM therapy | |
| C: Only CPM therapy |
I intervention group, C control group, RCT randomised controlled trial, CPM continuous passive motion, QES quasi-experimental study, OA osteoarthritis, TKA total knee arthroplasty, CD compact disk, RCPS randomized controlled pilot study, CPSP chronic postsurgical pain, CCTWAA controlled clinical trial with alternating allocation, CBT cognitive behavioural therapy, NRCT non-randomised controlled trial
*Preoperative education about care pathway, knee surgery, pain management, expected discharge goals and in-patient and out-patient arthroplasty rehabilitation by an educational nurse and a booklet
**Preadmission preoperative teaching with an instruction booklet during a preoperative outpatient clinic visit. Upon admission to the hospital, they were presented with an educational videotape
***A booklet containing symptom management after TKA, an individual teaching session, and a follow-up support call by the principal investigator
****25-Min sessions of nurse-patient interaction and discussion regarding specific exercises and physical activity, self-monitoring, goal setting, family support and encouragement, and information prompting
$Guided imagery is a widely used mind–body intervention by the generation of self- or practitioner-guided positive sensory and affective mental images to promote health changes in the body, reducing anxiety and stress, and evoking psychological and physiologic relaxation [61]
#Intervention addressed to the recovery of physical function, the concerns during the recovery period and strategies for coping with pain after the operation delivered by trained therapists
^The video was established to produce positive and therapeutic insight, according to the Videoinsight Methods principles [65]
The influence of perioperative interventions targeting psychological distress on pain after the TKA
| Type of intervention | Study | Nr TKA | Females (%) | Age | Follow-up | Outcome score (pain) | I | C | Statistically significance at latest follow-up | |
|---|---|---|---|---|---|---|---|---|---|---|
| Music | Allred 2010 | T | 56 | 31 (55.4) | 63.9 (64-84)* | 6 hours | VAS | 41.2 ± 25.8 | 45.1 ± 31.2 | |
| I | 28 | MPQ | 15.9 ± 10.6 | 14.9 ± 12.3 | ||||||
| C | 28 | Opioid use (morphine or dilaudid) | na | na | ||||||
| Aris 2019 | T | 56 | 60 minutes | VAS | 0 (24.39 ** | 1.5 (32.61)** | ||||
| I | 28 | 19 (67.9) | 63.71±11.005 | |||||||
| C | 28 | 19 (67.9) | 64.50±8.851 | |||||||
| Chen 2015 | T | 30 | 20 (66.7) | 68 (53-85)* | Postoperative days | VAS (recovery) | 3.22 ± 0.22*** | 3.00 ± 0.25*** | ||
| I | 15 | VAS (ward) | 3.07 ± 0.26*** | 2.87 ± 0.18*** | ||||||
| C | 15 | Opioid use (parenteral morphine, meperidine, fentanyl in PO recovery) | 7.39 ± 2.66 | 6.86 ± 2.29 | ||||||
| Opioid use (parenteral morphine, meperidine, fentanyl in the ward) | 12.04 ± 14.43 | 12.90 ± 8.05 | ||||||||
| Hsu 2019 | T | 49 | 34 (69.4) | 73.9 ± 7.5 | 2 days | NRS | 0.06 ± 0.24 | 2.14 ± 1.10 | ||
| I | 49 | |||||||||
| C | 49 | |||||||||
| Keshmiri 2014 | T | 83 | 52 (62.7) | 68.7 ± 0.96 | 2-7 days | VAS (day 1-3) | 1.33 ± 0.11 (I1) & 1.44 ± 0.13 (I2) | 1.49 ± 0.13 | ||
| I1 | 28 | VAS (day 4-7) | 0.9 ± 0.15 (I1) & 0.81 ± 0.13 (I2) | 1.23 ± 0.19 | ||||||
| I2 | 27 | VAS (day 17) | 1.09 ± 0.12 (I1) & 1.08 ± 0.11 (I2) | 1.34 ± 0.14 | ||||||
| C | 28 | Days of pain catheter duration (type of pain medication na) | 3.43 ± 0.11 (I1) 7 3.48 ± 0.12 (I2) | 3.36 ± 0.19 | ||||||
| Leonard 2019 | T | 32 | Postoperative days | NRS | 5.44 ± 3.2 | 5.56 ± 2.52 | "No significant difference" | |||
| I | 16 | 11 (68.8) | 67.9 (45-87)* | Observational coding for pain | 3.06 ± 3.13 | 2.31 ± 2.36 | ||||
| C | 16 | 12 (75) | 67.6 (53-80)* | |||||||
| Santhna 2015 | T | 40 | 14 (70) 18 (90) | 63.80±5.64 64.90±6.94 | 5 (days) | PRI | 11.78^ | 29.23^ | ||
| I | 20 | |||||||||
| C | 20 | VAS | 14.20^ | 26.80^ | ||||||
| PPI | 15.00^ | 26.00^ | ||||||||
| Paracetamol | 16000mg^^ | 17000 mg^^ | ||||||||
| Celecoxib | 600 mg^^ | 1600 mg^^ | ||||||||
| Tramadol | 125 mg^^ | 225 mg^^ | ||||||||
| Simcock 2008 | T | 30 | 18 (60) | 67.3±9.1 | 24 hours | VAS (3 hours PO) | 3.87 ± 3.44 | 1.47 ± 1.39 | ||
| I | 15 | VAS (6 hours PO) | 5.26 ± 3.04 | 3.38 ± 2.48 | ||||||
| C | 15 | VAS (24 hours PO) | 4.03 ± 2.89 | 2.41 ± 1.67 | ||||||
| Education | Atabaki 2019 | T | 56 | 6 (weeks) | WOMAC | 40.47 ± 10.47 | 57.29 ± 7.51 | |||
| I | 48 | 46 (95.8) | 65.39 ± 5.08 | |||||||
| C | 48 | 41 (85.4) | 63.83 ± 5.14 | |||||||
| Aytekin 2019 | T | 44 | 6 months | VASpr | 0.4 ± 0.9 | 0.8 ± 1.1 | "no significant difference between groups" | |||
| I | 23 | 18 (78.3) | 67.8 ± 6.3 | VASpa | 1.5 ± 1.5 | 2.3 ± 2.3 | "no significant difference between groups" | |||
| C | 21 | 18(85.7) | 69.7 ± 6.4 | KOOSpain | 87.9 ± 15.4 | 92.7 ± 8.3 | "no significant difference between groups" | |||
| Chen 2014 | T | 92 | 63 (68.5) | 69.26 ± 9.025 | 5 days | NRS (worst pain) | 4.89 ± 2.82 | 5.57 ± 2.84 | ||
| I | 42 | NRS (average pain) | 2.38 ± 1.97 | 2.43 ± 2.03 | ||||||
| C | 50 | NRS (current pain) | 2.46 ± 2.31 | 2.57 ± 2.26 | ||||||
| Huang 2011 | T | 242 | 174 (71.6) | 70.2 ± 7.3 | 5 days | VAS | 2.4 ± 0.7 | 2.5 ± 0.6 | ||
| I | 125 | |||||||||
| C | 117 | |||||||||
| Louw 2019 | T | 103 | 6 (months) | NRS | na | na | ||||
| I | 49 | 32 (65.3%) | 74.1 ± 9.5 | Morfine | 2601.62 ± 1103.90 | 2734.02 ± 1324.60 | ||||
| C | 54 | 23 (51.9) | 69.6 ± 10.6 | |||||||
| Mallet-schek 2019 | T | 75 | 47 (62.7) | 59-78* | 3 months | KOOSpain | na | na | ||
| I | 37 | |||||||||
| C | 38 | |||||||||
Lee 2019 | T | 24 | 6 months | NRS | 1.40 ± 0.89 (I1) & 1.73 ± 1.40 (I2) | 2.23 ± 1.41 | HYP vs. control: MET vs. Control: | |||
| I1 | 8 | 7 (87.5) | 65.63 ± 9.27 | |||||||
| I2 | 8 | 7 (87.5) | 56.25 ± 11.22 | |||||||
| C | 8 | 8 (100) | 67.88 ± 10.38 | |||||||
| Moulton 2017 | T | 563 | na | 70.1 ± na | 2 years | OKS (6 months PO) | 28.71 ± na | 31.60 ± na | ||
| I | 503 | OKS (2 years PO) | 30.17 ± na | 33.26 ± na | ||||||
| C | 60 | |||||||||
| Piva 2017 | T | 44 | 31 (70.5) | 6 months | WOMAC pain | min 1.7 (95% CI -3.0,-4.0) ^^^ | min 0.3 (95% CI - 1.5, 1.0) ^^^ | |||
| I | 22 | 68.1 ± 7.5 | ||||||||
| C | 22 | 68.3 ± 5.5 | ||||||||
| Reslan 2018 | T | 60 | na | 4 weeks | HSSpain | 22.83 ± 4.78 | 19.18 ± 5.14 | |||
| I | 30 | 19 (63.6) | ||||||||
| C | 30 | 17 (56.7) | ||||||||
| Timmers 2019 | T | 213 | 4 weeks after discharge | NRS at rest | 3.45^ | 4.59^ | ||||
| I | 114 | 74 (64.9) | 64.74 ± 7.57 | NRS activity | 3.99^ | 5.08^ | ||||
| C | 99 | 60 (60.6) | 65.63 ± 7.90 | NRS at night | 4.18^ | 5.21^ | ||||
| Wilson 2016 | T | 143 | 89 (62.6) | 3 days | BPI-I | 24.4 ± 14.4 | 22.4 ± 15.1 | |||
| I | 73 | 67 ± 8 | NRS (rest) | 2.8 ± 2.5 | 2.8 ± 2.7 | |||||
| C | 70 | 66 ± 8 | NRS (moving) | 5.4 ± 3.0 | 6.1 ± 2.5 | |||||
| NRS worst pain last 24 hours) | 7.0 ± 2.4 | 7.0 ± 2.3 | P = 0.87 | |||||||
| Opioid use (morphine, hydroporphone, oxycodon, codeine) | 40 (45)*^ | 40 (42)*^ | "no difference between groups in daily 24-hours opioid administration" | |||||||
| Yajnik 2018 | T | 40 | 3 (7.5) | 68 (46-80)* | 2 days | Opioid use (morphine, MME PO day 1 and 2) | 38 (1-117)* | 72 (32-285)* | ||
| I | 20 | Minimum pain (patients’ verbal rating 0–10) 1 day PO | 0 (0 - 3)* | 0 (0 - 6)* | ||||||
| C | 20 | Maximum pain (patients’ verbal rating 0–10) 1 day PO | 4 (2 - 9)* | 8 (1 - 10)* | ||||||
| Psycho-therapy | Birch 2019 | T | 60 | 1 (year) | VAS activity | 12 (5-18)^^^ | 9 (3-15) ^^^ | |||
| I | 31 | 22 (33) | 66 ± 9 | VAS rest | 7 (1–12)^^^ | 6 (1–12) ^^^ | ||||
| C | 29 | 18 (27) | 66 ± 10 | |||||||
| Cai 2017 | T | 108 | 6 months | KSS | 82.61 ± 6.38 | 73.30 ± 8.45 | ||||
| I | 54 | 31 (57.4) | 62.42 ± 6.59 | |||||||
| C | 54 | 34 (63.0) | 63.94 ± 6.58 | |||||||
| Cai 2018 | T | 100 | 62 (55.9) | 6 months | NRS | 5.63 ± 0.73 | 6.27 ± 0.86 | time effects: | ||
| I | 50 | 65.26 ± 8.30 | ||||||||
| C | 50 | 66.18 ± 7.04 | ||||||||
| Das Nair 2018 | T | 50 | 23 (46) | WOMAC pain | 6.5 ± 3.6 | 7.5 ± 2.3 | ||||
| I | 25 | 65.7 ± 8.6 | ICOAP constant pain (item 1-5) | 6.4 ± 4.4 | 6.2 ± 3.2 | |||||
| C | 25 | 66.7 ± 9.9 | ICOAP constant pain (item 1, 3, 4, 5) | 4.8 ± 3.7 | 5.1 ± 3.0 | |||||
| ICOAP constant pain (converted rasch score item 1, 3, 4, 5) | 5.5 ± 4.1 | 6.0 ± 3.2 | ||||||||
| ICOAP intermittent pain (item 6-11) | 8.5 ± 5.6 | 10.2 ± 4.5 | ||||||||
| ICOAP intermittent pain (item 6, 7, 10, 11) | 5.7 ± 3.8 | 7.1 ± 3.3 | ||||||||
| ICOAP intermittent pain (converted rasch score item 6, 7, 10 11) | 5.5 ± 3.4 | 6.7 ± 3.0 | ||||||||
| Jacobson 2016 | T | 58 | 51 (62.2) | 65 (41-81)* | 6 months | WOMAC pain | 2.7 ± 3.1 | 3.5 ± 3.3 | ||
| I | 29 | VAS daily pain | na | na | ||||||
| C | 29 | |||||||||
| Riddle 2011 | T | 63 | 45 (71.4) | 2 months | WOMAC pain | 6.0 ± 4.1 | 8.6 ± 3.7 | |||
| I | 18 | 63.8 ± 11.5 | ||||||||
| C | 45 | 60.8 ± 9.9 | ||||||||
| Riddle 2019 | T | 402 | 12 months | WOMAC pain | 3.3 (95% CI 2.5, 4.2) (I1) & 3.0 (95% CI 2.1, 3.8) (I2)^^^ | 2.9 (95% CI 2.0, 3.8)^^^ | ||||
| I1 | 130 | 94 (72.3) | 62.6 ± 7.9 | NRS | 1.8 (95% CI 1.2, 2.4) (I1) & 2.0 (95% CI 1.3,2.6) (I2) ^^^ | 1.7 (95% CI 1.1, 2.2) ^^^ | ||||
| I2 | 135 | 85 (63.0) | 64.2 ± 8.5 | |||||||
| C | 137 | 88 (64.2) | 62.7 ± 7.7 | |||||||
| Tristaino 2015 | T | 64 | 44 (62.0) | 4 months | SF-36 bodily pain | 70.1 ± 21.5 | 67.8 ± 26.8 | |||
| I | 33 | 64.2 ± 8.6 | ||||||||
| C | 31 | 66.1 ± 6.6 | ||||||||
| Remaining | Baldwin 2017 | T | 56 | na | na | 72 hours | VAS | na | na | "Reiki significant pain reduction ( |
| I1 | 25 | Opioid use (oxycontin, oxycodone, morphine) | na | na | ||||||
| I2 | 12 | |||||||||
| C | 19 | |||||||||
| Hiraga 2019 | T | 41 | 4 weeks | NRS rest | 1.3 ± 0.4 | 1.2 ± 0.4 | ||||
| I | 20 | 16 (80) | 76.4 ± 7.1 | NRS walk | 1.3 ± 0.2 | 3.2 ± 0.6 | ||||
| C | 21 | 19 (90.4) | 76.6 ± 5.5 | |||||||
| Koo 2018 | T | 120 | 5 weeks | VAS | na (figure) | na (figure) | "No signicance was found in VAS analyses between the groups" | |||
| I | 60 | 17 (28.3) | 65.00 ± 6.97 | |||||||
| C | 60 | 15 (25) | 63.71 ± 5.09 | |||||||
| Notte 2016 | T | 43 | na | na | 3 days postoperatively | NRS | na | na | ||
| I | 23 | Opioid use (type of opioid na) | na | na | ||||||
| C | 20 | |||||||||
| Wang 2015 | T | 66 | 23 (34.9) | 73.5 ± 9.5 | 5 days | NRS | 3.36 ± 1.47 | 4.23 ± 1.67 | ||
| I | 33 | Opioid use (pethidine PO day 5) | 1 (3.2) | 0 (0.0) | ||||||
| C | 33 | PMU (Acetaminophen or COX-2 inhibitor + pethidine or tramadol PO day 5) | 24 (77.4) | 21 (63.6) | ||||||
Nr number; TKA total knee arthroplasty; SD standard deviation; I intervention group; C control group; T total study group; VAS visual analog scale; P P value; MPQ short form McGill pain questionnaire; na: not available; PO postoperative; NRS numeric rating score; PRI Pain Rating intensity; PPI Present Pain Intensity; mg milligram; WOMAC Western Ontario and McMaster universities osteoarthritis index; VASpr visual analog scale pain resting; VASpa visual analog scale pain acitivity; KOOSpain pain subscale of the knee injury and osteoarthritis outcome score; HYP hypnotic intervention; MET minimal-effect treatment; OKS Oxford knee score; 95% CI 95% confidence interval; HSS hospital for special surgery; BPI-I Brief Pain Inventory interference; MME Morphine Milligram Equivalents; NS not significant; KSS knee society score; ICOAP Intermittent and Constant Osteoarthritis Pain scale; SF-36 Short Form-36; SOC stand of care; PMU pain medication use; COX-2 cyclooxygenase-2
Instead of mean and SD: *median (range), **median and mean rank, ***mean and standard error, ^mean rank only, ^^median only, ^^^mean estimate with the 95% CI in parentheses, *^median (interquartile range) instead of mean and SD
The influence of perioperative interventions targeting psychological distress on function after the TKA
| Type of intervention | Study | Nr TKA | Females (%) | Age mean ± SD | Follow-up | Outcome score (function) | I score ± SD | C score ± SD | Statistically significance at latest follow-up | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Music | Hsu [35] | T | 91 | 67 (73.6) | 2 days | CPM angles 1 day PO | 24.29 ± 5.00 | 12.98 ± 4.43 | |||
| I | 49 | 73.9 ± 7.5 | CPM angles 2 days PO | 21.22 ± 2.98 | 16.07 ± 4.49 | ||||||
| C | 42 | 71.33 ± 8.45 | Active knee flexion ROM 2 days PO | 106.22 ± 6.17 | 95.00 ± 6.80 | ||||||
| Hsu [36] | T | 49 | 2 days | Increased degree of knee flexion during CPM | 21.22 ± 2.98 | 10.02 ± 3.03 | |||||
| I | 49 | 34 (69.4) | 73.9 ± 7.5 | ||||||||
| C | 49 | 34 (69.4) | 73.9 ± 7.5 | ||||||||
| Leonard [38] | T | 32 | Postoperative days | Observational coding for pedalling adherence | 7.81 ± 0.40 | 7.44 ± 1.21 | "No significant difference" | ||||
| I | 16 | 11 (68.8) | 67.9 (45–87)* | ||||||||
| C | 16 | 12 (75) | 67.6 (53–80)* | ||||||||
| Education | Atabaki [41] | T | 96 | 6 weeks | WOMAC stiffness | 19.53 ± 12.34 | 41.66 ± 10.09 | ||||
| I | 48 | 46 (95.8) | 65.39 ± 5.08 | WOMAC performance difficulty | 43.48 ± 7.96 | 55.82 ± 4.30 | |||||
| C | 48 | 41 (85.4) | 63.83 ± 5.14 | ||||||||
| Aytekin [42] | T | 44 | 6 months | KOOS total | 82.2 ± 16.1 | 85.5 ± 9.5 | "No significant difference between groups" | ||||
| I | 23 | 18 (78.3) | 67.8 ± 6.3 | KOOSdaily living activities | 87.2 ± 18.3 | 91.1 ± 9.2 | "No significant difference between groups" | ||||
| C | 21 | 18(85.7) | 69.7 ± 6.4 | KOOSsports | 52.8 ± 24.4 | 56.1 ± 13.1 | "No significant difference between groups" | ||||
| Chen [43] | T | 92 | 63 (68.5) | 69.26 ± 9.025 | 5 days | Overall rating of nine physical function items | 12.38 ± 2.806 | 12.05 ± 3.682 | |||
| I | 42 | Ankle pumping | 1.55 ± 0.39 | 1.54 ± 0.44 | |||||||
| C | 50 | Quadriceps setting | 0.17 ± 0.39 | 0.23 ± 0.43 | |||||||
| Knee flexion/extension | 0.44 ± 0.53 | 0.69 ± 0.66 | |||||||||
| Straight-leg raises | 1.22 ± 2.58 | 0.64 ± 0.56 | |||||||||
| MPOAL | 3.71 ± 0.622 | 3.08 ± 1.090 | |||||||||
| Huang 2011 | T | 242 | 174 (71.6) | 70.2 ± 7.3 | 5 days | Ability to walk during discharge | 85.7 ± na | 81.2 ± na | |||
| I | 125 | ROM | 76 ± 22 | 74 ± 20 | |||||||
| C | 117 | ||||||||||
| Huang [45] | T | 150 | 102 (68.0) | 3 months | ROM ITT ROM PP | 110.6 ± 6.68 110.0 ± 6.33 | 105.00 ± 8.82 103.26 ± 7.57 | ||||
| I | 75 | 62.42 ± 6.59 | |||||||||
| C | 75 | 63.94 ± 6.58 | |||||||||
| Lin [47] | T | 60 | 31 (51.7) | 68.6 ± na | EPC | 14.93 ± na | 8.87 ± na | ||||
| I | 30 | Knee flexion | 77.84 ± na | 70.16 ± na | |||||||
| C | 30 | Ambulation ability | na | na | "The differences between groups were not significant" | ||||||
| Louw [48] | T | 101 | 6 months | WOMAC | na | na | |||||
| I | 49 | 32 (65.3) | 74.1 ± 9.5 | ||||||||
| C | 54 | 23 (51.9) | 69.6 ± 10.6 | ||||||||
| Malletschek 2019 | T | 75 | 47 (62.7) | 59 – 78** | 3 months | KSS | na | na | |||
| I | 37 | ||||||||||
| C | 38 | ||||||||||
| Moulton [50] | T | 563 | na | 70.1 ± na | 2 years | OKS (6 months PO) | 28.71 ± na | 31.60 ± na | |||
| I | 503 | ||||||||||
| C | 60 | ||||||||||
| OKS (2 years PO) | 30.17 ± na | 33.26 ± na | |||||||||
| Piva [51] | T | 44 | 31 (70.5) | 6 months | SF-36 PF | 76.7 ± 16.1 | 70.3 ± 24.2 | ||||
| I | 22 | 68.1 ± 7.5 | Single-leg stance test | 16.1 ± 9.6 | 17.4 ± 9.8 | ||||||
| C | 22 | 68.3 ± 5.5 | WOMAC PF | 11.8 ± 6.7 | 12.8 ± 10.8 | ||||||
| Stair-climb | 14.3 ± 4.1 | 15.6 ± 7.4 | |||||||||
| Chair-stand | 12.2 ± 2.8 | 13.7 ± 7.5 | |||||||||
| 6-Min walk | 472.6 ± 86.5 | 518.0 ± 103.3 | |||||||||
| Gait speed | 1.14 ± 0.16 | 1.18 ± 0.24 | |||||||||
| Daily activity | 152.5 ± 93.3 | 174.9 ± 126.1 | |||||||||
| Reslan [52] | T | 60 | 4 weeks | HSSfunction | 15.73 ± 3.49 | 13.92 ± 3.35 | |||||
| I | 30 | 19 (63.6) | na | HSSrom | 17.04 ± 2.55 | 16.53 ± 4.20 | |||||
| C | 30 | 17 (56.7) | na | HSSquadriceps muscle strength | 9.13 ± 3.81 | 8.47 ± 2.93 | |||||
| HSSflexion deformity | 10.02 ± 1.21 | 8.47 ± 1.93 | |||||||||
| HSSinstability | 9.89 ± 3.41 | 8.27 ± 2.89 | |||||||||
| LEFS | 60.35 ± 11.22 | 53.83 ± 12.98 | |||||||||
| Timmers [53] | T | 213 | 4 weeks after discharge | KOOS | 37.61 ± 10.17 | 43.08 ± 12.96 | |||||
| I | 114 | 74 (64.9) | 64.74 (7.57) | Ability to perform physiotherapy | 7.50*** | 6.88*** | |||||
| C | 99 | 60 (60.6) | 65.63 (7.90) | Ability to perform self-care activities | 8.32*** | 7.64*** | |||||
| Yajnik 2018 | T | 40 | 3 (7.5) | 68 (46–80)* | 2 days | Maximum ambulation 1 day PO | 20 (0–59)^ | 12 (0–30) ^ | |||
| I | 20 | Maximum ambulation 2 days PO | 46 (6–67)^ | 38 (0–61) ^ | |||||||
| C | 20 | ||||||||||
| Psycho-herapy | Birch 2019 | T | 60 | 1 year | OKS | 33 (29, 27)^^ | 37 (33, 41)^^ | ||||
| I | 31 | 22 (33) | 66 (9) | 6-Min walk | 441 (402,480)^^ | 406 (367, 446)^^ | |||||
| C | 29 | 18 (27) | 66 (10) | Sit to stand | 12 (11, 14) ^^ | 11 (95% CI 10,13) ^^ | |||||
| Cai [57] | T | 108 | 6 months | KSS | 82.61 ± 6.38 | 73.30 ± 8.45 | |||||
| I | 54 | 31 (57.4) | 62.42 ± 6.59 | First time out of bed (hours) | 22.13 ± 4.18 | 36.41 ± 7.31 | |||||
| C | 54 | 34 (63.0) | 63.94 ± 6.58 | ||||||||
| Cai [58] | T | 100 | 62 (55.9) | 6 months | HSS function | 80.68 ± 8.02 | 68.98 ± 8.64 | ||||
| I | 50 | 65.26 ± 8.30 | |||||||||
| C | 50 | 66.18 ± 7.04 | |||||||||
| Das Nair [59] | T | 50 | 23 (46.0) | 6 months | WOMAC function | 20.9 ± 12.7 | 32.0 ± 4.8 | ||||
| I | 25 | 65.7 ± 8.6 | WOMAC stiffness | 3.2 ± 1.9 | 4.2 ± 0.9 | ||||||
| C | 25 | 66.7 ± 9.9 | |||||||||
| Harnirattisai [60] | T | 63 | 59 (93.7) | 67.88 (60–85)* | 6 weeks | PTT total | 8.86 ± 1.89 | 6.43 ± 1.66 | |||
| I | 42 | PPT standing balance | Δ 2.00 ± 1.22^^^ | Δ 1.09 ± 1.22^^^ | |||||||
| C | 21 | PPT walking speed | Δ 1.55 ± 1.02^^^ | Δ 0.76 ± 0.83^^^ | |||||||
| PPT chair-stand | Δ 2.36 ± 1.05^^^ | Δ 1.33 ± 1.02^^^ | |||||||||
| ADL and daily requirements exercise activity | na | na | "There were no significant differences in ADL participation" | ||||||||
| Jacobson [61] | T | 58 | 51 (62.2) | 65 (41–81)* | 6 months | SF-36 physical | 50.4 ± 6.0 | 47.3 ± 7.5 | |||
| I | 29 | WOMAC stiffness | 1.9 ± 1.4 | 2.1 ± 1.9 | |||||||
| C | 29 | WOMAC function | 7.2 ± 7.1 | 10.2 ± 10.5 | |||||||
| Gait velocity | na | na | |||||||||
| Timed walk in seconds | 7.4 ± 2.2 | 8,5 ± 2.3 | |||||||||
| Riddle [62] | T | 63 | 45 (71.4) | 2 months | WOMAC disability | 18.3 ± 12.2 | 24.1 ± 10.9 | ||||
| I | 18 | 63.8 ± 11.5 | |||||||||
| C | 45 | 60.8 ± 9.9 | |||||||||
| Riddle [63] | T | 402 | 12 months | WOMACfunction | 11.7 (8.6, 14.9) (I1) & 12.2 (9.0, 15.4) (I2)^^ | 10.5 (7.4, 13.6)^^ | |||||
| I1 | 130 | 94 (72.3) | 62.6 ± 7.9 | SPPB | 8.0 (7.2, 8.7) (I1) & 8.4 (7.6, 9.1) (I2)^^ | 8.6 (95% CI 7.8, 9.4)^^ | |||||
| I2 | 135 | 85 (63.0) | 64.2 ± 8.5 | ||||||||
| C | 137 | 88 (64.2) | 62.7 ± 7.7 | ||||||||
| Russo 2016 | T | 110 | na | 69.1 ± na | 3 months | SF-36 physical | 45.6 ± 8.3 | 46.2 ± 9.9 | |||
| I | 55 | KSS | 87.8 ± 9.6 | 78.3 ± 8.2 | |||||||
| C | 55 | WOMAC | 79.9 ± 13.0 | 69.7 ± 9.5 | |||||||
| VAS functional score | 2.8 ± 1.6 | 4.0 ± 1.5 | |||||||||
| Tristaino 2015 | T | 44 | 44 (62.0) | 4 months | SF-36 PCS | 49.5 ± 6.6 | 50.9 ± 9.8 | ||||
| I | 33 | 64.2 ± 8.6 | Days until physiotherapy objective reached | 8.1 ± 2.4 | 8.8 ± 2.3 | ||||||
| C | 31 | 66.1 ± 6.6 | |||||||||
| Remaining | Chistriansen 2015 | T | 26 | 13 (50) | 26 weeks | FTSST | 9.5 ± 2.4 | 9.6 ± 1.6 | |||
| I | 13 | 68.2 ± 8.6 | Hip moment (Nm/kg) during FTSST | 0.65 ± 0.24 | 0.63 ± 0.20 | ||||||
| C | 13 | 66.6 ± 8.1 | Knee moment (Nm/kg) during FTSST | 1.03 ± 0.22 | 0.97 ± 0.11 | ||||||
| Ankle moment (Nm/kg) during FTSST | 0.17 ± 0.16 | 0.24 ± 0.14 | |||||||||
| Walking speed (m/s) | 1.29 ± 0.25 | 1.24 ± 0.13 | |||||||||
| Hip moment during walking | 0.28 ± 0.19 | 0.36 ± 0.22 | |||||||||
| Knee extension moment during walking | 0.61 ± 0.25 | 0.42 ± 0.44 | |||||||||
| Ankle moment during walking | 0.09 ± 0.29 | 0.01 ± 0.19 | |||||||||
| Hiraga [68] | T | 41 | 4 weeks | Daily step count | 3580.5 ± 1545.2 | 2088.4 ± 2008.3 | |||||
| I | 20 | 16 (80) | 76.4 ± 7.1 | Psychical activity time | 1741.4 ± 551.3 | 731.8 ± 321.1 | |||||
| C | 21 | 19 (90.4) | 76.6 ± 5.5 | ||||||||
| Koo [69] | T | 120 | 5 weeks | WOMAC | 14.59 ± 9.14 | 10.86 ± 10.84 | |||||
| I | 60 | 17 (28.3) | 65.00 ± 6.97 | Graded ambulation distance | na | na | |||||
| C | 60 | 15 (25) | 63.71 ± 5.09 | 6-Min walk test | 407.00 ± 83.62 | 353.35 ± 82.35 | |||||
| Timed-stand test | 19.29 ± 2.80 | 19.00 ± 6.16 | |||||||||
Nr Number, TKA total knee arthroplasty, SD standard deviation, I intervention group, C control group, T total study group, CPM continuous passive motion, PO postoperative, P P value, ROM range of motion, WOMAC Western Ontario and McMaster Universities osteoarthritis index, KOOS Knee Injury and Osteoarthritis Outcome Score, MPOAL muscle power of the affected leg, ITT intention to treat, PP per protocol, na not available, EPC exercises performance checklist, KSS Knee Society Score, OKS Oxford knee score, SF-36 PF Short Form-36 physical functioning, HSS hospital for special surgery knee score, NS not significant, LEFS lower extremity functional scale, POD postoperative day, PPT physical performance test, ADL activities of daily living, SPPB short physical performance battery, VAS visual analog scale, PCS physical component scale, FTSST five-time sit-to-stand test, Nm/kg Newtonmeter/kilogram, m/s metre per second
Instead of mean and SD
*Mean (range)
**Range only
***Mean only
^Median (10th–90th percentiles)
^^Mean estimate with the 95% CI parentheses
^^^Mean change score baseline—6 weeks postoperative
The influence of perioperative interventions targeting psychological distress on QoL after the TKA
| Type of intervention | Study | Nr TKA | Females (%) | Age mean ± SD | Follow-up | Outcome score (QoL) | I score ± SD I score ± SD | C score ± SD | Statistically significance at latest follow-up | |
|---|---|---|---|---|---|---|---|---|---|---|
| Education | Malletscheck 2019 | T | 75 | 47 (62.7) | 59–78* | 3 months | KOOS QoL | na | na | |
| I | 37 | |||||||||
| C | 38 | |||||||||
| Timmers 2019 | T | 213 | 4 weeks after discharge | EQ-5D | 0.76 ± 0.16 | 0.67 ± 0.25 | P < 0.001 | |||
| I | 114 | 74 (64.9) | 64.74 ± 7.57 | |||||||
| C | 99 | 60 (60.6) | 65.63 ± 7.90 | |||||||
Nr Number, TKA total knee arthroplasty, SD standard deviation, QoL quality of life, I intervention group, C control group, T total study group, KOOS Knee Injury and Osteoarthritis Outcome Score, na not available, P P value, NS not significant, EQ-5D EuroQOL Five-Dimensional Questionnaire
Instead of mean and SD
*Range
Fig. 2Risk of bias summary. Authors' judgements about each risk of bias item for each included study. Green: low risk of bias. Red: high risk of bias. No fill: unclear risk of bias
Fig. 3Risk of bias graph. Authors' judgements about each risk of bias item presented as percentages across all included studies. Green: low risk of bias. Red: high risk of bias. No fill: unclear risk of bias
The overall level of evidence using the GRADE approach
| Certainty assessment | No of patients | Certainty | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | ITPD | No ITPD | |||||||
| Pain (follow up: range 60 min to 6 months; assessed with: Various outcome measures) | |||||||||||||||
| 34 | 19 randomised trials and 15 remaining* | Serious | Serious | Serious | Not serious | all plausible residual confounding would suggest spurious effect, while no effect was observed | 1618 | 996 | ⨁⨁◯◯ low | ||||||
| Function (follow up: range 2 days to 2 years; assessed with: Various outcome measures) | |||||||||||||||
| 29 | 16 randomised trials and 13 remaining** | Serious | Serious | Serious | Not serious | all plausible residual confounding would suggest spurious effect, while no effect was observed | 1580 | 1003 | ⨁⨁◯◯ low | ||||||
| QoL (follow up: range 24 weeks to 3 months; assessed with: Various outcome measures) | |||||||||||||||
| 2 | 1 randomised trial and one non-randomised trial | Serious | Serious | Not serious | Not serious | all plausible residual confounding would suggest spurious effect, while no effect was observed | 151 | 137 | ⨁⨁⨁◯ moderate | ||||||
GRADE grading of recommendation, assessment, development, and evaluation, № number, ITPD intervention targeting psychological distress, QoL quality of life
*8 prospective cohort studies, 6 quasi-experimental studies, 1 retrospective cohort study
**6 prospective cohort studies, 6 quasi-experimental studies, 1 retrospective cohort study